Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mitesh J Borad

Showing results (1-10 of 223) with videos related to

Pageof 23
Sort By:
Plos One|July 31, 2024
Introducing the PLOS collection on rare cancerMitesh J Borad
Journal of Gastrointestinal Oncology|October 18, 2016
The rise of the FGFR inhibitor in advanced biliary cancer: the next cover of time magazine?Sumera I Ilyas, Mitesh J Borad
Mayo Clinic Proceedings|October 7, 2017
Twenty-First Century Precision Medicine in Oncology: Genomic Profiling in Patients With CancerMitesh J Borad, Patricia M LoRusso
Cureus|September 30, 2017
Hypoxia-Activated Alkylating Agents in BRCA1-Mutant Ovarian Serous CarcinomaMichael Conroy, Mitesh J Borad, Alan H Bryce
Expert Opinion on Investigational Drugs|December 14, 2021
Precision approaches for cholangiocarcinoma: progress in clinical trials and beyondPedro Luiz Serrano Uson Junior, Mitesh J Borad
Seminars in Liver Disease|March 7, 2023
Targeting Fibroblast Growth Factor Receptor Pathway: Precision Medicine for Biliary Cancer and BeyondPedro Luiz Serrano Uson Junior, Mitesh J Borad
Cancer Management and Research|September 25, 2023
Clinical Utility of Ivosidenib in the Treatment of IDH1-Mutant Cholangiocarcinoma: Evidence To DatePedro Luiz Serrano Uson Junior, Mitesh J Borad
F1000Research|December 12, 2013
Advances in systemic therapy for advanced pancreatobiliary malignanciesThorvardur R Halfdanarson, Sigurdis Haraldsdottir, Mitesh J Borad
F1000Research|December 24, 2013
Advances in systemic therapy for advanced pancreatobiliary malignanciesThorvardur R Halfdanarson, Sigurdis Haraldsdottir, Mitesh J Borad
Immunotherapy|June 15, 2018
Exploring the role of oncolytic viruses in hepatobiliary cancersPavan Tenneti, Mitesh J Borad, Hani M Babiker
Pageof 23

Showing results (1-10 of 223) with videos related to

Sort By:
Pageof 23
Plos One|July 31, 2024
Introducing the PLOS collection on rare cancerMitesh J Borad
Journal of Gastrointestinal Oncology|October 18, 2016
The rise of the FGFR inhibitor in advanced biliary cancer: the next cover of time magazine?Sumera I Ilyas, Mitesh J Borad
Mayo Clinic Proceedings|October 7, 2017
Twenty-First Century Precision Medicine in Oncology: Genomic Profiling in Patients With CancerMitesh J Borad, Patricia M LoRusso
Cureus|September 30, 2017
Hypoxia-Activated Alkylating Agents in BRCA1-Mutant Ovarian Serous CarcinomaMichael Conroy, Mitesh J Borad, Alan H Bryce
Expert Opinion on Investigational Drugs|December 14, 2021
Precision approaches for cholangiocarcinoma: progress in clinical trials and beyondPedro Luiz Serrano Uson Junior, Mitesh J Borad
Seminars in Liver Disease|March 7, 2023
Targeting Fibroblast Growth Factor Receptor Pathway: Precision Medicine for Biliary Cancer and BeyondPedro Luiz Serrano Uson Junior, Mitesh J Borad
Cancer Management and Research|September 25, 2023
Clinical Utility of Ivosidenib in the Treatment of IDH1-Mutant Cholangiocarcinoma: Evidence To DatePedro Luiz Serrano Uson Junior, Mitesh J Borad
F1000Research|December 12, 2013
Advances in systemic therapy for advanced pancreatobiliary malignanciesThorvardur R Halfdanarson, Sigurdis Haraldsdottir, Mitesh J Borad
F1000Research|December 24, 2013
Advances in systemic therapy for advanced pancreatobiliary malignanciesThorvardur R Halfdanarson, Sigurdis Haraldsdottir, Mitesh J Borad
Immunotherapy|June 15, 2018
Exploring the role of oncolytic viruses in hepatobiliary cancersPavan Tenneti, Mitesh J Borad, Hani M Babiker
Pageof 23